Abbvie, Novo Nordisk and Takeda have the best reputations among pharmaceutical companies, according to a new study, which also suggests that overall public perceptions of the industry are improving.
Cambrex, a leading manufacturer of small molecules and generic active pharmaceutical ingredients (APIs), has expanded large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden, and introduced additional continuous flow manufacturing to produce high-purity intermediates. The expansion includes the installation of new multi-purpose reactors ranging from 4m3 to 12m3 and upgrading of the control room within an existing plant on site. This extra capacity increases the large-scale manufacturing capabilities of the Karlskoga facility, which supports clients’ development projects from R&D through to large scale commercial manufacturing. Installation of all new equipment, including a 9m³ hydrogenation reactor, is expected to be completed by 3Q17.
Reverse osmosis membrane elements from specialty chemicals company Lanxess have successfully completed a year-long practical test in Germany's largest industrial water treatment plant. The new ASD feed spacers showed a consistently high level of rejection, with less blockage from fouling or biological growth over the year, compared with standard elements.
Ten start-ups will see their ideas for more sustainable chemistry move a step closer to reality after being named winners of AkzoNobel’s Imagine Chemistry challenge.
Published: June 8, 2017